Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Long-Term Investments: 2024

Historic Long-Term Investments for Praxis Precision Medicines (PRAX) over the last 1 years, with Dec 2024 value amounting to $77.0 million.

  • Praxis Precision Medicines' Long-Term Investments rose 125.35% to $122.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.0 million, marking a year-over-year increase of 125.35%. This contributed to the annual value of $77.0 million for FY2024, which is N/A change from last year.
  • Praxis Precision Medicines' Long-Term Investments amounted to $77.0 million in FY2024.
  • Over the past 5 years, Praxis Precision Medicines' Long-Term Investments peaked at $77.0 million during FY2024, and registered a low of $77.0 million during FY2024.
  • In the last 1 years, Praxis Precision Medicines' Long-Term Investments had a median value of $77.0 million in 2024 and averaged $77.0 million.